Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Short Interest Update

Basilea Pharmaceutica AG (OTCMKTS:BPMUF - Get Free Report) was the recipient of a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 3,600 shares, an increase of 3,500.0% from the March 31st total of 100 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is presently 36.0 days. Approximately 0.0% of the company's stock are sold short.

Basilea Pharmaceutica Stock Performance

Basilea Pharmaceutica stock remained flat at $47.50 during trading hours on Thursday. The company has a current ratio of 4.10, a quick ratio of 3.27 and a debt-to-equity ratio of 5.70. The business's fifty day simple moving average is $52.26 and its 200 day simple moving average is $52.63. Basilea Pharmaceutica has a one year low of $47.50 and a one year high of $54.00.

Basilea Pharmaceutica Company Profile

Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.